KALV KalVista Pharmaceuticals, Inc.
$27.00▲ +0.00%
Healthcare
Other
Volume 4.26M
Avg Volume (10D) 2.09M
Key Metrics & Fundamentals
Market Cap
$1.44B
P/E Ratio
–
Div Yield
–%
52W Range
9.83 - 27.00
% vs 50 MA
11.14%
% vs 200 MA
58.99%
RSI-14
75.9
MACD Histogram
-0.2100
Beta (1Y vs SPY)
0.85
Free Cash Flow
-$14.66M
Gross Rev
$40.86M
Gross Profit
$37.77M
EBITDA
-$17.49M
COGS
$3.09M
Operating Exp
$61.22M
Operating Income
-$23.44M
EBIT
-$23.44M
Pretax Income
-$23.49M
Net Income
-$23.49M
EPS (Diluted)
-0.43
Price & Volume History
Loading chart…
Recent News
No recent news found for KALV.
Financial Overview - Income Statement
Quarterly
Mar 2026
See KALV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.